Biote Corp. BTMD Unsatisfied Pellet Procedures — Contract With Customer Liability Current
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Biote Corp. in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.
The official record: Biote Corp.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Biote Corp.'s unsatisfied pellet procedures — contract with customer liability current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Biote Corp.'s unsatisfied pellet procedures — contract with customer liability current?
- Biote Corp. (BTMD) reported unsatisfied pellet procedures — contract with customer liability current of $1.3M in Q1 2026.
- How has Biote Corp.'s unsatisfied pellet procedures — contract with customer liability current changed year-over-year?
- Biote Corp.'s unsatisfied pellet procedures — contract with customer liability current decreased by 2.0% year-over-year, from $1.33M to $1.3M.
- What is the long-term trend for Biote Corp.'s unsatisfied pellet procedures — contract with customer liability current?
- Over 2 years (2023 to 2025), Biote Corp.'s unsatisfied pellet procedures — contract with customer liability current has grown at a 22.9% compound annual growth rate (CAGR), from $3.63M to $5.48M.
- What does unsatisfied pellet procedures — contract with customer liability current mean?
- This metric represents the current portion of deferred revenue associated with hormone pellet procedures that have been paid for by practitioners or patients but have not yet been performed. It serves as a key indicator of short-term service obligations and future revenue recognition within the next twelve months. Monitoring this balance helps investors assess the near-term demand for hormone optimization services and the company's ability to fulfill its contractual commitments.